Autor/in Eggemann, H Eiermann, W 1 Friedrichs, K Hilfrich, J 1 Jackisch, C 1 Kühn, T Kümmel, S 1 Markmann, S 1 Rezai, M Schneeweiss, A 1 Warm, M alle zeigenListe einklappen
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use. Eiermann, W Rezai, M Kümmel, S Kühn, T Warm, M Friedrichs, K Schneeweiss, A 2013 - Forschungsinformationssystem des UKE
